Innoviva, Inc. (INVA)
21.02
+0.08
(+0.38%)
USD |
NASDAQ |
Oct 28, 11:17
Innoviva Market Cap : 1.527B for Oct. 28, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 27, 2026 | 1.521B |
| October 26, 2026 | 1.529B |
| October 23, 2026 | 1.501B |
| October 22, 2026 | 1.530B |
| October 21, 2026 | 1.519B |
| October 20, 2026 | 1.546B |
| October 19, 2026 | 1.531B |
| October 16, 2026 | 1.509B |
| October 15, 2026 | 1.515B |
| October 14, 2026 | 1.523B |
| October 13, 2026 | 1.506B |
| October 12, 2026 | 1.558B |
| October 09, 2026 | 1.541B |
| October 08, 2026 | 1.516B |
| October 07, 2026 | 1.530B |
| October 06, 2026 | 1.513B |
| October 05, 2026 | 1.499B |
| October 02, 2026 | 1.489B |
| October 01, 2026 | 1.493B |
| September 30, 2026 | 1.541B |
| September 29, 2026 | 1.533B |
| September 28, 2026 | 1.542B |
| September 25, 2026 | 1.506B |
| September 24, 2026 | 1.501B |
| September 23, 2026 | 1.470B |
| Date | Value |
|---|---|
| September 22, 2026 | 1.524B |
| September 21, 2026 | 1.528B |
| September 18, 2026 | 1.536B |
| September 17, 2026 | 1.529B |
| September 16, 2026 | 1.540B |
| September 15, 2026 | 1.514B |
| September 14, 2026 | 1.518B |
| September 11, 2026 | 1.501B |
| September 10, 2026 | 1.498B |
| September 09, 2026 | 1.535B |
| September 08, 2026 | 1.550B |
| September 04, 2026 | 1.549B |
| September 03, 2026 | 1.551B |
| September 02, 2026 | 1.551B |
| September 01, 2026 | 1.531B |
| August 31, 2026 | 1.509B |
| August 28, 2026 | 1.523B |
| August 27, 2026 | 1.522B |
| August 26, 2026 | 1.543B |
| August 25, 2026 | 1.538B |
| August 24, 2026 | 1.528B |
| August 21, 2026 | 1.530B |
| August 20, 2026 | 1.525B |
| August 19, 2026 | 1.560B |
| August 18, 2026 | 1.544B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 350.25B |
| Zevra Therapeutics, Inc. | 604.69M |
| ANI Pharmaceuticals, Inc. | 1.622B |
| Corcept Therapeutics, Inc. | 9.475B |
| Veru, Inc. | 38.70M |
Market Cap Related Metrics
| PE Ratio | 5.121 |
| PS Ratio | 3.804 |
| PEG Ratio | 0.0045 |
| Price to Book Value | 1.238 |
| Price to Free Cash Flow | 9.112 |
| Price | 21.02 |
| Earnings Yield | 19.53% |
| PEGY Ratio | 0.0045 |
| Operating PE Ratio | 10.62 |
| Normalized PE Ratio | 9.193 |